Liposomal daunorubicin in the treatment of relapsed or refractory non-Hodgkin's lymphoma.
Tulpule A, Rarick MU, Kolitz J, Bernstein J, Myers A, Buchanan LA, Espina BM, Traynor A, Letzer J, Justice GR, McDonald D, Roberts L, Boswell W, Nathwani B, Levine AM.
Tulpule A, et al. Among authors: espina bm.
Ann Oncol. 2001 Apr;12(4):457-62. doi: 10.1023/a:1011181016401.
Ann Oncol. 2001.
PMID: 11398876
Free article.
Clinical Trial.